Carrier Protein

Carrier Protein designates an immunogenic protein used in vaccine design to enhance immune responses against weak antigens, particularly polysaccharides that do not elicit strong T-cell dependent immunity on their own. By chemically conjugating a polysaccharide antigen to a carrier protein, the immune system is stimulated to produce more robust antibody responses and immunological memory. Common carrier proteins include tetanus toxoid, diphtheria toxoid, and CRM197, selected for established safety profiles and strong immune stimulation properties.

The vaccine industry depends heavily on carrier proteins for developing conjugate vaccines that protect infants and young children against serious bacterial infections. Carrier selection impacts vaccine performance, including immunogenicity strength, durability of protection, and potential immune interference when multiple conjugates are combined in multivalent formulations. Manufacturing considerations include ensuring consistent conjugation chemistry, controlling conjugate ratios, and maintaining antigen integrity. Regulatory evaluation includes characterising carrier protein identity, confirming conjugation consistency, and demonstrating clinical efficacy across target populations. As vaccine technology expands into novel conjugate platforms and broader pathogen coverage, carrier proteins remain central to enabling effective immune responses against traditionally challenging antigen types.